Find a Drug
Advanced Search

Professional

Hyalgan

Clinical Pharmacology
font size

Clinical Pharmacology

 

TABLE 7
Subjects' Categorical Assessments of Pain
for Completed Subjects in Prior 48 Hours:
Level of Pain by Treatment Group
at Baseline and Week 26
 
NUMBER (%) OF SUBJECTS IN CATEGORY
 
Hyalgan® Placebo Naproxen
 
Baseline Week 26 Baseline Week 26 Baseline Week 26
None (0)
1 (1.0) 23 (21.9) 0 (0.0) 14 (12.2) 0 (0.0) 13 (11.5)
Slight (1)
2 (1.9) 27 (25.7) 0 (0.0) 24 (20.9) 1 (0.9) 31 (27.4)
Mild (2)
6 (5.7) 19 (18.1) 8 (7.0) 24 (20.9) 7 (6.2) 26 (23.0)
Moderate (3)
62 (59.0) 26 (24.8) 78 (67.8) 40 (34.8) 72 (63.7) 31 (27.4)
Marked (4)
34 (32.4) 10 (9.5) 29 (25.2) 13 (11.3) 33 (29.2) 12 (10.6)
TOTAL
105 (100) 105 (100) 115 (100) 115 (100) 113 (100) 113 (100)

TABLE 8
Hyalgan® Effect as a Percentage of the Naproxen-Placebo Difference
Assessment
Hyalgan®
(HYL)
Placebo
(PLA)
Naproxen
(NAP)
HYL-PLA NAP-HYL NAP-PLA (HYL-PLA)
% of
(NAP-PLA)
VAS for 50 foot
Walk
Baseline Adjusted
Mean Effect
Sizes From
ANCOVA
      -8.85 mm
on a 100 mm
VAS
4.12 mm
on a 100 mm
VAS
-4.73 * mm
on a 100 mm
VAS
187%
  
  
% of Subjects
Improved by
Masked Evaluators
78.1 69.6 73.2 8.5 -4.9 3.6 236%
% of Subjects
Improved
by Subjects
73.3 62.6 67.3 10.7 -6.0 4.7 228%
*Imputed as (NAP-HYL) + (HYL-PLA).
Note that Effectiveness Success Criterion D is satisfied since ((HYL-PLA) % of (NAP-PLA))>50% for all three of the above pain assessments.


Additional Analyses

Brand Name: Hyalgan
Generic Name: Hyaluronate

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Bookmark this page:

Arthritis

Get the latest treatment options

WebMD Symptom Checker - Start Here Ringworm Slideshow: Watch and Learn

Knee Cartilage RestorationKnee Cartilage Restoration
Advances in technology are helping painful old knees work like new again. See more WebMD Videos »